Accretion Nutraveda IPO
Accretion Nutraveda IPO is a book build issue of ₹24.77 cr, which is entirely a fresh issue of shares. This is a book-building IPO with a price band set at ₹122 to ₹129 per share and the lot size for an application is 1,000. The minimum amount of investment required by an individual investor (retail investor) is ₹2,58,000 (2,000 shares). Accretion IPO will open for subscription on January 27, 2026 and closes on January 30, 2026, which will list on the BSE SME platforms with a tentative listing date fixed as Feb 4, 2026.
Company Background
Accretion Nutraveda Ltd., established in 2021, is a specialized manufacturer of Ayurvedic and Nutraceutical solutions, operating as a robust Contract Development and Manufacturing Organization (CDMO). The company offers a diverse product portfolio across multiple dosage forms, including tablets, oils and powders, targeting critical health areas such as liver care and cognitive support. With a state-of-the-art, WHO-GMP certified facility in Gujarat, it serves prominent markets in the USA and Singapore. Backed by experienced promoters, the firm maintains a strong competitive edge through its dual focus on domestic merchant exports and rapidly growing direct international sales.
